Clinton Vision Source - Medicare Optometrist in Clinton, OK

Clinton Vision Source is a medicare enrolled "Optometrist" provider in Clinton, Oklahoma. Their current practice location is 565 S 30th St, Clinton, Oklahoma. You can reach out to their office (for appointments etc.) via phone at (580) 323-5421.

Clinton Vision Source is licensed to practice in Oklahoma (license number 918) and it also participates in the medicare program. Clinton Vision Source is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1902083280.

Contact Information

Clinton Vision Source
565 S 30th St,
Clinton, OK 73601-3656
(580) 323-5421
(866) 585-2957



Healthcare Provider's Profile

Full NameClinton Vision Source
TypeFacility
SpecialityOptometrist
Location565 S 30th St, Clinton, Oklahoma
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1902083280
  • Provider Enumeration Date: 01/29/2008
  • Last Update Date: 09/27/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 9931260379
  • Enrollment ID: O20081204000236

Medical Identifiers

Medical identifiers for Clinton Vision Source such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1902083280NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist 918 (Oklahoma)Primary
332H00000XEyewear Supplier (* (Not Available))Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Clinton Vision Source acts as a billing entity for following providers:
Provider NameMarshall Patrick Day
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1588614960
PECOS PAC ID: 8628139060
Enrollment ID: I20081204000274

News Archive

Scientists sequence Clostridium botulinum genome that produces neurotoxin

Scientists on the Norwich Research Park have sequenced the genome of a novel strain of Clostridium botulinum, one of the most dangerous pathogens known to man. The strain produces an unusual botulinum neurotoxin, known as type A5 neurotoxin, which was isolated by the Health Protection Agency, following a case of wound botulism.

Focus on treating malnutrition in cancer patients, researchers say

Cancer patients who are malnourished experience significantly greater levels of psychological distress than those who are more adequately nourished, according to new results reported at the European Society for Medical Oncology's Symposium on Cancer and Nutrition (Zurich, 20-21 March 2009).

Dengue vaccine from Takeda shows promise

Officials have confirmed the initial success with trials of Dengue vaccine. Dengue, a viral disease borne by mosquitoes is considered to be one of the top ten health threats says the world Health Organization (WHO). Since the beginning of the outbreaks and the hundreds of deaths due to this infection, researchers have been on the lookout for vaccines to prevent this infection.

NeoStem prices public offering of 5M common stock shares at $1.35 per share

NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced today that it priced a public offering of 5,000,000 shares of its common stock at $1.35 per share. Net proceeds from the offering, after underwriting discounts and commissions and expenses, will be approximately $5,697,500. NeoStem has granted the underwriters an option to purchase up to an additional 750,000 shares to cover over-allotments, if any.

Read more Medical News

› Verified 8 days ago

Provider NameRandi L Day
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1063678449
PECOS PAC ID: 7810058252
Enrollment ID: I20081204000413

News Archive

Scientists sequence Clostridium botulinum genome that produces neurotoxin

Scientists on the Norwich Research Park have sequenced the genome of a novel strain of Clostridium botulinum, one of the most dangerous pathogens known to man. The strain produces an unusual botulinum neurotoxin, known as type A5 neurotoxin, which was isolated by the Health Protection Agency, following a case of wound botulism.

Focus on treating malnutrition in cancer patients, researchers say

Cancer patients who are malnourished experience significantly greater levels of psychological distress than those who are more adequately nourished, according to new results reported at the European Society for Medical Oncology's Symposium on Cancer and Nutrition (Zurich, 20-21 March 2009).

Dengue vaccine from Takeda shows promise

Officials have confirmed the initial success with trials of Dengue vaccine. Dengue, a viral disease borne by mosquitoes is considered to be one of the top ten health threats says the world Health Organization (WHO). Since the beginning of the outbreaks and the hundreds of deaths due to this infection, researchers have been on the lookout for vaccines to prevent this infection.

NeoStem prices public offering of 5M common stock shares at $1.35 per share

NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced today that it priced a public offering of 5,000,000 shares of its common stock at $1.35 per share. Net proceeds from the offering, after underwriting discounts and commissions and expenses, will be approximately $5,697,500. NeoStem has granted the underwriters an option to purchase up to an additional 750,000 shares to cover over-allotments, if any.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Clinton Vision Source is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Clinton Vision Source
Po Box 606,
Clinton, OK 73601-0606

Ph: (580) 323-5421
Clinton Vision Source
565 S 30th St,
Clinton, OK 73601-3656

Ph: (580) 323-5421

News Archive

Scientists sequence Clostridium botulinum genome that produces neurotoxin

Scientists on the Norwich Research Park have sequenced the genome of a novel strain of Clostridium botulinum, one of the most dangerous pathogens known to man. The strain produces an unusual botulinum neurotoxin, known as type A5 neurotoxin, which was isolated by the Health Protection Agency, following a case of wound botulism.

Focus on treating malnutrition in cancer patients, researchers say

Cancer patients who are malnourished experience significantly greater levels of psychological distress than those who are more adequately nourished, according to new results reported at the European Society for Medical Oncology's Symposium on Cancer and Nutrition (Zurich, 20-21 March 2009).

Dengue vaccine from Takeda shows promise

Officials have confirmed the initial success with trials of Dengue vaccine. Dengue, a viral disease borne by mosquitoes is considered to be one of the top ten health threats says the world Health Organization (WHO). Since the beginning of the outbreaks and the hundreds of deaths due to this infection, researchers have been on the lookout for vaccines to prevent this infection.

NeoStem prices public offering of 5M common stock shares at $1.35 per share

NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced today that it priced a public offering of 5,000,000 shares of its common stock at $1.35 per share. Net proceeds from the offering, after underwriting discounts and commissions and expenses, will be approximately $5,697,500. NeoStem has granted the underwriters an option to purchase up to an additional 750,000 shares to cover over-allotments, if any.

Read more News

› Verified 8 days ago


Optometrist in Clinton, OK

Dr. Randi Loraine Day, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 818 Frisco Ave, Clinton, OK 73601
Phone: 580-440-0077    Fax: 580-200-1096
Randi L Day Od Llc
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 818 Frisco Ave, Clinton, OK 73601
Phone: 580-440-0077    Fax: 580-200-1096
Marshall Patrick Day, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 565 S 30th Street, Clinton, OK 73601
Phone: 580-323-5421    Fax: 866-585-2957
James D Coffey O D P C
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 817 Avant Ave, Suite 2, Clinton, OK 73601
Phone: 580-323-1515    Fax: 580-323-2521
Richard B Madden, O.D.
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 125 S 10th St, Clinton, OK 73601
Phone: 580-323-0337    Fax: 580-323-0330
Dr. James Doyle Coffey, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 817 Avant Ave, Suite 2, Clinton, OK 73601
Phone: 580-323-1515    Fax: 580-323-2521

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.